JI-101
目录号: A13545
VEGFR2/PDGFRβ/EphB4 抑制剂
JI-101 是一种口服活性抑制剂,针对血管内皮生长因子受体2(VEGFR2)、衍生自血小板的生长因子受体β(PDGFRβ)和Ephrin B4受体B4(EphB4),具有潜在的抗血管生成和抗肿瘤活性。
Discription | JI-101 is an orally active inhibitor of vascular endothelial growth factor receptor 2 (VEGFR2), platelet-derived growth factor receptor beta (PDGFRβ), and the ephrin B4 receptor B4 (EphB4) with potential antiangiogenic and antineoplastic activities. | ||
---|---|---|---|
Targets |
|
目录号 | A13545 |
---|---|
分子式 | C22H20BrN5O2 |
分子量 | 466.3305 |
CAS号 | 900573-88-8 |
SMILES | COC1=C(C=C(C=C1)Br)NC(=O)NC2=CC=CC3=C2C=CN3CC4=CC(=NC=C4)N |
其他名称 | JI 101, JI101 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2